The impact of delayed adjuvant chemotherapy on survival in gastric cancer patients with and without preoperative chemotherapy

Abstract Aim Adjuvant chemotherapy (AC) is the standard treatment for patients with advanced gastric cancer (GC), yet the optimal timing for its initiation remains unclear. Besides, no studies have definitively established when AC should begin in patients receiving preoperative chemotherapy (PC). Th...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Masataka Shimonosono, Takaaki Arigami, Daisuke Matsushita, Yusuke Tsuruda, Ken Sasaki, Kenji Baba, Takao Ohtsuka
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2025-07-01
coleção:	Annals of Gastroenterological Surgery
Assuntos:	adjuvant chemotherapy gastric cancer neoadjuvant chemotherapy perioperative medicine survival
Acesso em linha:	https://doi.org/10.1002/ags3.12911
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!